European Academy of Neurology guidelines on the treatment of cluster headache

A May, S Evers, PJ Goadsby, M Leone… - European Journal of …, 2023 - Wiley Online Library
Abstract Background and Purpose Cluster headache is a relatively rare, disabling primary
headache disorder with a major impact on patients' quality of life. This work presents …

Cluster headache, SUNCT, and SUNA

M Burish - CONTINUUM: Lifelong Learning in Neurology, 2024 - journals.lww.com
Objective This article reviews the epidemiology, clinical features, differential diagnosis,
pathophysiology, and management of three types of trigeminal autonomic cephalalgias …

Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis

H Yuan, A Natekar, J Park, CG Lauritsen… - Regional Anesthesia & …, 2023 - rapm.bmj.com
Introduction Subanesthetic ketamine infusion has been used for managing refractory
headache in inpatient or outpatient infusion settings. Intranasal ketamine may be an …

Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management

NH Strand, M Whitney, B Johnson, T Dunn… - Current Pain and …, 2025 - Springer
Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain
Management | Current Pain and Headache Reports Skip to main content Springer Nature …

Psychotropic Drugs Reemerging as Headache Medicines

EAD Schindler - CNS drugs, 2024 - Springer
Scientific and public attention on the therapeutic effects of psychedelics and other
psychoactive compounds in headache disorders has recently grown. The use and reported …

Ketamine as Treatment for Cluster Headache: A Systematic Review of Literature and a Case Series

J Neumann, H Bornemann-Cimenti… - Pain and Therapy, 2024 - Springer
Methods In this mixed-methods paper, we first summarize the available evidence of
ketamine for treatment of cluster headache based on a systematic review of literature in …

Neues bei Kopfschmerzen 2022–2023

HC Diener, D Holle-Lee, C Gaul - Neurologie up2date, 2023 - thieme-connect.com
Dieser Übersicht beschäftigt sich mit neuen Erkenntnissen zur Migräne, zu Kopfschmerzen
vom Spannungstyp, anderen primären und sekundären Kopfschmerzen sowie zur …

A systematic review of the efficacy of ketamine for craniofacial pain

Y Hoydonckx, T McKechnie, M Peer… - Canadian Journal of …, 2023 - Taylor & Francis
Background Craniofacial pain (CFP) poses a burden on patients and health care systems. It
is hypothesized that ketamine, an N-methyl-d-aspartate (NMDA) receptor antagonist, can …

丛集性头痛发作前驱期口服佐米曲普坦的疗效和安全性

刘唯, 陆佳洁, 郭效宁, 许春阳, 严满云, 张全全… - 徐州医科大学 …, 2023 - xb.xzhmu.edu.cn
目的探讨发作性丛集性头痛(eCH) 患者前驱期口服佐米曲普坦的疗效和安全性.
方法对处于丛集期内且存在前驱期的23 例eCH 患者, 收集基线头痛发作资料, 并分别在3 …

Real-world study of intranasal ketamine for use in patients with refractory chronic migraine

H Yuan, A Natekar, JS Park, C Lauritsen, ER Viscusi… - medRxiv, 2022 - medrxiv.org
Subanesthetic ketamine infusion has been used for managing refractory headache in
inpatient or outpatient infusion settings. Intranasal (IN) ketamine may be an alternative …